Antiviral therapy in the improvement of survival of patients with hepatitis B virus-related hepatocellular carcinoma treated with sorafenib

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Treatment of intermediate-stage hepatocellular carcinoma

(2014) Alejandro Forner et al.   Nature Reviews Clinical Oncology

Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis

(2014) Lei Liu et al.   PLoS One

Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Treatment with Transarterial Chemoembolization Combined with Sorafenib—A Retrospective Controlled Study

(2014) Kangshun Zhu et al.   RADIOLOGY

A long-term study of the effects of antiviral therapy on survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation

(2014) Hie-Won Hann et al.   Cancer Medicine

Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma

(2013) Qiang-Bo Zhang et al.   PLoS One

Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses

(2013) Gwang Hyeon Choi et al.   RADIOLOGY

Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection

(2012) Chun-Ying Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Sorafenib: activity and clinical application in patients with hepatocellular carcinoma

(2011) Yong-Song Guan et al.   EXPERT OPINION ON PHARMACOTHERAPY

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma

(2010) Chau-Ting Yeh et al.   HEPATOLOGY

Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: Does transarterial chemoembolization improve survival in these patients?

(2010) Dong-Jun Yoo et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma

(2010) Ho Jung An et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Recurrence of Hepatitis B-Related Hepatocellular Carcinoma Is Associated With High Viral Load at the Time of Resection

(2008) Ivan F. N. Hung et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma

(2008) Yi-Fu He et al.   ANNALS OF HEMATOLOGY

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

(2008)   JOURNAL OF HEPATOLOGY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib inhibits activation of human peripheral blood T cells by targeting LCK phosphorylation

(2008) W Zhao et al.   LEUKEMIA

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE